LEUKEMIA ACUTE MYELOID - AML

Clinical trials for LEUKEMIA ACUTE MYELOID - AML explained in plain language.

Never miss a new study

Get alerted when new LEUKEMIA ACUTE MYELOID - AML trials appear

Sign up with your email to follow new studies for LEUKEMIA ACUTE MYELOID - AML, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Completed 1

Targeted drug tested as new hope for Tough-to-Treat leukemia

Disease control Completed

This study tested whether a new targeted pill called gilteritinib (ASP2215) worked better than standard salvage chemotherapy for adults with a specific genetic type of acute myeloid leukemia (AML) that had come back or did not respond to first treatment. The main goals were to se…

Matched conditions: LEUKEMIA ACUTE MYELOID - AML

Phase: PHASE3 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

LEUKEMIA ACUTE MYELOID - AML

Get alerted when new LEUKEMIA ACUTE MYELOID - AML trials appear

Targeted drug tested as new hope for Tough-to-Treat leukemia